- Filed
- Feb 4, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Feb 2, 2026 | 26.39M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2025 | 26.29M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2025 | 26.39M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2024 | 26.62M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2024 | 26.73M sh |
| Stock Repurchased | Q3 2026 · Dec 31, 2025 | $24.32M |
| Stock Repurchased | Q3 2026 · Dec 31, 2024 | $33.46M |
| Dividends Paid | Q3 2026 · Dec 31, 2025 | $13.13M |
| Dividends Paid | Q3 2026 · Dec 31, 2024 | $0 |
| Capex | Q3 2026 · Dec 31, 2025 | $3.25M |
| Capex | Q3 2026 · Dec 31, 2024 | $3.41M |
| Operating Cash Flow | Q3 2026 · Dec 31, 2025 | −$221.19M |
| Operating Cash Flow | Q3 2026 · Dec 31, 2024 | $141.2M |
| Cash And Equivalents | Q3 2026 · Dec 31, 2025 | $326.29M |
| Cash And Equivalents | Q3 2026 · Mar 31, 2025 | $389.38M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | $1.06B |
| Stockholders Equity | Q3 2026 · Sep 30, 2025 | $1.05B |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | $1.02B |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | $977.62M |
| Stockholders Equity | Q3 2026 · Dec 31, 2024 | $962.34M |
| Stockholders Equity | Q3 2026 · Sep 30, 2024 | $947M |
| Stockholders Equity | Q3 2026 · Jun 30, 2024 | $921.93M |
| Stockholders Equity | Q3 2026 · Mar 31, 2024 | $901.78M |
| Current Liabilities | Q3 2026 · Dec 31, 2025 | $682.09M |
| Current Liabilities | Q3 2026 · Mar 31, 2025 | $797.88M |
| Total Liabilities | Q3 2026 · Dec 31, 2025 | $768.39M |
| Total Liabilities | Q3 2026 · Mar 31, 2025 | $907.18M |
| Current Assets | Q3 2026 · Dec 31, 2025 | $1.45B |
| Current Assets | Q3 2026 · Mar 31, 2025 | $1.36B |
| Total Assets | Q3 2026 · Dec 31, 2025 | $1.83B |
| Total Assets | Q3 2026 · Mar 31, 2025 | $1.88B |
| Eps Diluted | Q3 2026 · Dec 31, 2025 | $1.33 |
| Eps Diluted | Q3 2026 · Dec 31, 2025 | $4.08 |
| Eps Diluted | Q3 2026 · Dec 31, 2024 | $0.91 |
| Eps Diluted | Q3 2026 · Dec 31, 2024 | $3.10 |
| Eps Basic | Q3 2026 · Dec 31, 2025 | $1.34 |
| Eps Basic | Q3 2026 · Dec 31, 2025 | $4.10 |
| Eps Basic | Q3 2026 · Dec 31, 2024 | $0.91 |
| Eps Basic | Q3 2026 · Dec 31, 2024 | $3.12 |
| Sga Expense | Q3 2026 · Dec 31, 2025 | $108.7M |
| Sga Expense | Q3 2026 · Dec 31, 2025 | $320.12M |
| Sga Expense restated | Q3 2026 · Dec 31, 2024 | $100.93M |
| Sga Expense restated | Q3 2026 · Dec 31, 2024 | $286.07M |
| Net Income | Q3 2026 · Dec 31, 2025 | $35.05M |
| Net Income | Q3 2026 · Dec 31, 2025 | $107.6M |
| Net Income | Q3 2026 · Sep 30, 2025 | $34.86M |
| Net Income | Q3 2026 · Jun 30, 2025 | $37.7M |
| Net Income | Q3 2026 · Dec 31, 2024 | $24.13M |
| Net Income | Q3 2026 · Dec 31, 2024 | $82.78M |
| Net Income | Q3 2026 · Sep 30, 2024 | $31.31M |
| Net Income | Q3 2026 · Jun 30, 2024 | $27.34M |
| Operating Income | Q3 2026 · Dec 31, 2025 | $43.47M |
| Operating Income | Q3 2026 · Dec 31, 2025 | $128.5M |
| Operating Income restated | Q3 2026 · Dec 31, 2024 | $16.47M |
| Operating Income restated | Q3 2026 · Dec 31, 2024 | $74.93M |
| Gross Profit | Q3 2026 · Dec 31, 2025 | $158.65M |
| Gross Profit | Q3 2026 · Dec 31, 2025 | $468.99M |
| Gross Profit restated | Q3 2026 · Dec 31, 2024 | $125.08M |
| Gross Profit restated | Q3 2026 · Dec 31, 2024 | $379.25M |